Current research focuses on combining hyperthermia with so-called „Immune check-point inhibitors”. Inhibitors of control points reduce the suppression of cytotoxic T lymphocytes and activate them to attack cancer cells. By. preclinical data: the effectiveness of T lymphocytes in attacking cancer cells is 3 times higher at 39.5 ° C than at 37 ° C.
You can find a list of selected papers to this topic in our section Bibliography/HT and Immonumodulation
Belgradzka street 5
+48 22 300 91 85
Monday - Friday from 8:00 to 18:00